華昊中天醫藥-B

02563
3.4000.29% ( -0.010 )
延遲 已收盤: 11月20日 16:08:00

股東

全部股東

股東類型

  • 私人企業44.90%
  • 公眾及其他19.99%
  • 創投/私募13.84%
  • 機構投資者8.90%
  • 其他12.37%

主要股東

主要股東 最新
股東
Baygen QT Inc
10.40%4,050.59 萬0.71%+031/03/2026
Shanghai Xin Sheng De Yuan Enterprise Management Centre (Limited Partnership)
8.93%3,479.83 萬--+3,479.83 萬16/07/2026
Tibet Xinsheng Deyuan Venture Capital Management Co., Ltd
8.93%3,479.83 萬0.61%+031/12/2025
SDIC (Shanghai) Venture Capital Management Co., Ltd.
7.55%2,942.67 萬0.52%+031/12/2025
Baiyang Pharmaceutical Group Co., Ltd.
7.49%2,917.08 萬--+2,917.08 萬16/07/2026
Li TangCo-Founder, Chairperson, Chief Scientific Officer & Chief Marketing Officer
7.44%2,898.65 萬0.51%+031/03/2026
Tibet Renhe Zhengtai Venture Capital Management Co., Ltd.
6.28%2,447.59 萬0.43%+031/03/2026
Shenzhen Efung Investment Management Limited Partnership Enterprise
5.60%2,182.73 萬0.38%+031/03/2026
Beijing Biostar Pharmaceuticals Co., Ltd, ESOP
4.93%1,922.09 萬0.34%+031/03/2026
Zhuhai Huajin Haoyuan Enterprise Management Partnership (Limited Partnership)
4.93%1,922.09 萬0.34%+031/12/2025
Zhuhai Huaxin Haoyuan Business Management Partnership (Limited Partnership)
3.59%1,400.20 萬0.25%+031/03/2026
Fortune Venture Capital Co., Ltd.
3.29%1,282.22 萬0.23%+025/06/2025
Zhuhai Huarong Haoyuan Enterprise Management Partnership (Limited Partnership)
0.51%200.03 萬0.04%+031/12/2025
Beijing Baygen Technologies Ltd.
0.11%41.96 萬<0.01%+031/03/2026
China Universal Asset Management Company Ltd.
<0.01%3.73 萬<0.01%+030/06/2025